human
***TASK*** the task is to summarize an input biomedical literature in six sentences 
    ***INPUT*** the input is a biomedical literature 
    ***OUTPUT*** the output is the summary of an input biomedical literature in six sentences 
    ***DOCUMENTATION*** 
    ***EXAMPLES*** 
    Input: BACKGROUND Serum thyroglobulin appears to be a sensitive marker of thyroid dysfunction in endemic goiter . However , its value as an indicator of thyroid status in children after the introduction of iodized salt  has not been tested . OBJECTIVE The objective was to optimize and vali date a thyroglobulin assay on dried whole blood spots and to evaluate thyroglobulin as an indicator of thyroid response to iodized salt . DESIGN A st and ardized , commercially available , s and wich fluoroimmunometric serum thyroglobulin assay was adapted for use on blood spots and vali date d in Swiss children . In a 1-y prospect i ve study in 377 goitrous Moroccan children aged 6 - 15 y , the assay was used to measure thyroglobulin before and after the introduction of iodized salt .  Urinary iodine , thyroid volume , thyrotropin , and thyroxine were measured , and regression was done with thyroglobulin as the dependent variable . RESULTS Correlation between the blood spot and serum assays was excellent ( r = 0.98 ) . The SD of the difference between the blood spot and serum assays was 3.8 micro g/L ; the median CVs for the blood spot assay in controls and sample s were 6.3 % and 14.4 % , respectively . Median thyroglobulin was 24.5 ( range : 0 - 328.8 ) micro g/L at baseline and fell significantly after the introduction of iodized salt to 6.2 ( 0 - 83.1 ) and 4.4 ( 0 - 47.1 ) micro g/L at 5 and 12 mo , respectively ( P < 0.0001 ) . Regression of urinary iodine and thyroid volume on thyroglobulin was highly significant at baseline and at 5 mo ( P < 0.001 ) . CONCLUSION Thyroglobulin , measured in dried whole blood spots , may be a valuable indicator of improving thyroid function in children after supplementation with iodized salt Iodine deficiency control programs have greatly reduced iodine deficiency disorders worldwide . For monitoring changes in iodine status , different indicators may be used . The aim of this study was to evaluate the suitability of indicators of iodine status and thyroid function , thyroglobulin ( Tg ) , thyroid-stimulating hormone ( TSH ) and free thyroxine ( FT4 ) in serum , thyroid volume and urinary iodine concentration , in iodine-deficient schoolchildren under conditions of increasing iodine supply . The study was established as a double-blind , placebo-controlled oral administration of a single dose of iodized oil to schoolchildren ( 7 - 10 y old ) , living in an iodine-deficient area of Benin , with an observation period of 10 mo . However , 3 - 4 mo after supplementation , iodized salt became available in the area . The study population therefore comprised an iodized oil-supplemented group  and a nonsupplemented group  , both of which had variable , uncontrolled intakes of iodized salt during the last 6 mo of the study . Initial mean serum concentrations of TSH and FT4 were within the normal range , whereas serum Tg concentration , urinary iodine concentration and thyroid volume were indicative of moderate-to-severe iodine deficiency . At the end of the study , all indicators had improved significantly , except thyroid volume , which had decreased only in the supplemented group . The supplemented group also still had significantly lower serum Tg and higher urinary iodine concentrations than the nonsupplemented group . Serum Tg and urinary iodine concentrations are the indicators most influenced by a changing iodine supply . Current normal reference ranges of serum concentrations of TSH and FT4 are too wide for detecting iodine deficiency in this age group BACKGROUND Infants are highly vulnerable to iodine deficiency , and little data exist on the effect of multiple micronutrient supplementation on their iodine status . OBJECTIVE We aim ed to compare the efficacy of daily and weekly multiple micronutrient food-like tablets ( foodLETs ) on increasing iodine status among infants . DESIGN In a double-blind , placebo-controlled trial , 133 Indonesian males aged 6 - 12 mo were r and omly assigned to 1 of 4 groups : a daily multiple-micronutrient foodLET providing the Recommended Nutrient Intake (RNI)(DMM ) , a weekly multiple-micronutrient foodLET providing twice the RNI ( WMM ) , a daily 10-mg Fe foodLET ( DI ) , or placebo .  Urinary iodine ( UI ) concentrations were measured at baseline and at 23 wk . RESULTS At baseline , the average UI concentration ( 1.37 micromol/L ) was within the normal range , and 30.8 % of subjects had iodine deficiency ( UI < 0.79 micromol/L ) . At 23 wk , the DMM group had the highest increment in UI ; however , after adjustment for initial UI , the changes in UI were not significantly different between the 4 groups ( P = 0.39 ) . Initial UI correlated inversely with the changes in UI ( P < 0.001 ) . The DMM group had the greatest reduction and increment in the proportion of iodine-deficient infants and in infants with iodine excess , respectively ; however , no significant difference was found in these proportions ( P = 0.13 and P = 0.42 ) between the 4 groups . CONCLUSION Daily consumption of a multiple-micronutrient foodLET providing the RNI during infancy may be one strategy to improve iodine status Iodized salt and iodized oil are the main methods used to prevent iodine deficiency , but sometimes alternative approaches are needed . We tested the efficacy of various regimens for the intermittent administration of potassium iodide in Hwedza , Zimbabwe , an area of known severe iodine deficiency . We divided 304 schoolchildren aged 7 - 13 y into five equal groups that received iodine as a 10 % solution of potassium iodide as follows : 8.7 mg every 2 wk ( group A ) , 29.7 mg every month ( group B ) , 148.2 mg every 3 mo ( group C ) , 382 mg every 6 mo ( group D ) , or 993 mg once ( group E ) . The follow-up period was 13 mo . No adverse effects were encountered with any of these doses . After 6 mo , the median blood spot thyroglobulin concentration had decreased in all groups and had normalized in groups A and B to values found in iodine-sufficient population s. The number of children with elevated thyroid-stimulating hormone concentrations decreased in groups A-C , but the changes were not significant . Urine iodine concentration generally remained low in all groups but increased in group A. After 13 mo , mean thyroid volume measured by ultrasound had decreased in groups A and B to values comparable with those in iodine-sufficient areas , and was unchanged in the other groups . We conclude that oral potassium iodide is effective for the prophylaxis of iodine deficiency if given as a dose of 30 mg I monthly or 8 mg biweekly BACKGROUND In developing countries , many children are at high risk of goiter and iron deficiency anemia . Because iron deficiency can have adverse effects on thyroid metabolism , iron deficiency may influence the response to supplemental iodine in areas of endemic goiter . OBJECTIVE The aim of this study was to determine whether goitrous children with iron deficiency anemia would respond to oral iodine supplementation . DESIGN A trial of oral iodine supplementation was carried out in an area of endemic goiter in western Côte d'Ivoire in goitrous children ( n = 109 ) aged 6 - 12 y. Group 1 ( n = 53 ) consisted of goitrous children who were not anemic . Group 2 ( n = 56 ) consisted of goitrous children who had iron deficiency anemia . At baseline , thyroid gl and volume and urinary iodine , thyrotropin , and thyroxine were measured by using ultrasound . Each child received 200 mg I orally and was observed for 30 wk , during which urinary iodine , thyrotropin , thyroxine , hemoglobin , and thyroid gl and volume were measured . RESULTS The prevalence of goiter at 30 wk was 12 % in group 1 and 64 % in group 2 . The mean percentage change from baseline in thyroid volume 30 wk after administration of oral iodine was -45.1 % in group 1 and -21.8 % in group 2 ( P < 0.001 ) . Among the anemic children , there was a strong correlation between the percentage decrease in thyroid volume and hemoglobin concentration ( r(2 ) = 0.65 ) . CONCLUSION The therapeutic response to oral iodine was impaired in goitrous children with iron deficiency anemia , suggesting that the presence of iron deficiency anemia in children limits the effectiveness of iodine intervention programs Iodine supplementation before pregnancy in iodine-deficient women prevents cretinism and neuromotor deficits in their offspring . It is unclear whether iodine supplementation benefits cognitive function in iodine-deficient school-aged children . We therefore conducted a double-blind , r and omized , controlled trial of the effects of iodized poppy seed oil ( Lipiodol ) on cognitive and motor function and weight gain of iodine-deficient school children . The study was conducted with 305 children in grade s 1 and 2 from 10 primary schools in two iodine-deficient areas in Bangladesh . The children were stratified by school and grade and r and omly assigned to receive 400 mg of oral Lipiodol or a placebo . All children were given a battery of cognitive and motor function tests and had their weights , serum thyroxine ( T4 ) and thyroid-stimulating hormone ( TSH ) and urinary iodine levels measured before and 4 mo after the intervention . On enrollment , both groups were moderately iodine deficient ( median urinary iodine values : placebo group = 3.3 micromol/L , n = 148 ; iodine group = 3.1 micromol/L , n = 152 ; goiter prevalence in both groups > 95 % ) . However , their T4 and TSH levels were within the normal range . After 4 mo , there was a significant treatment effect on urinary iodine levels ( P < 0.0001 ) , but the levels of the treated group were still below normal ( median = 7.9 micromol/L ) . No significant differences were found in T4 and TSH levels , weight gain , cognitive or motor function . The findings suggest that Lipiodol supplementation in moderately iodine-deficient children with normal T4 levels is unlikely to benefit their cognitive function . However , it remains possible that other iodine preparations may have benefits BACKGROUND Iodine is required for the production of thyroid hormones , which are necessary for normal brain development and cognition . Although several r and omized trials examined the effect of iodine supplementation on cognitive performance in schoolchildren , the results were equivocal . OBJECTIVE We aim ed to ascertain whether providing iodized oil to iodine-deficient children would affect their cognitive and motor performance . DESIGN In a double-blind intervention trial , 10 - 12-y-old children ( n = 310 ) in primary schools in rural southeastern Albania were r and omly assigned to receive 400 mg I ( as oral iodized oil ) or placebo . We measured urinary iodine ( UI ) , thyroid-stimulating hormone ( TSH ) , and total thyroxine ( TT4 ) concentrations and thyroid gl and volume ( by ultrasound ) . The children were given a battery of 7 cognitive and motor tests , which included measures of information processing , working memory , visual problem solving , visual search , and fine motor skills .  Thyroid ultrasound and the biochemical and psychological tests were repeated after 24 wk . RESULTS At baseline , the children 's median UI concentration was 43 microg/L ; 87 % were goitrous , and nearly one-third had low concentrations of circulating TT4 . Treatment with iodine markedly improved iodine and thyroid status : at 24 wk , median UI in the treated group was 172 microg/L , mean TT4 was approximately 40 % higher , and the prevalence of hypothyroxinemia was < 1 % . In the placebo group after the intervention , these variables did not differ significantly from baseline . Compared with placebo , iodine treatment significantly improved performance on 4 of 7 tests : rapid target marking , symbol search , rapid object naming , and Raven 's Coloured Progressive Matrices ( P < 0.0001 ) . CONCLUSION Information processing , fine motor skills , and visual problem solving are improved by iodine repletion in moderately iodine-deficient schoolchildren BACKGROUND Iodine deficiency ( even moderate ) plays a major role in pregnancy associated goiter development , which is only party reversible after pregnancy . The prevalence of post partum thyroiditis is reported to be slightly lower in areas of iodine deficiency . Thus iodine supplementation may be effective in decreasing pregnancy associated increase in thyroid volume , but enhances the risk of increasing the prevalence of thyroid dysfunction in the post partum period . Therefore , we evaluated the effect of iodine supplementation ( with two different doses : 50 microg and 250 microg ) on the prevalence of post partum thyroiditis and the decrease in thyroid volume up to 8 months post partum in an area of mild iodine defic 
    Output:
    
agent
Despite the high risk of bias of many of the included studies , the results suggested that urinary iodine , thyroglobin , serum thyroxine , and thyroid-stimulating hormone are useful biomarkers of iodine status , at least in some groups .
***TASK*** the task is to summarize an input biomedical literature in six sentences 
    ***INPUT*** the input is a biomedical literature 
    ***OUTPUT*** the output is the summary of an input biomedical literature in six sentences 
    ***DOCUMENTATION*** 
    ***EXAMPLES*** 
    Input: BACKGROUND Serum thyroglobulin appears to be a sensitive marker of thyroid dysfunction in endemic goiter . However , its value as an indicator of thyroid status in children after the introduction of iodized salt  has not been tested . OBJECTIVE The objective was to optimize and vali date a thyroglobulin assay on dried whole blood spots and to evaluate thyroglobulin as an indicator of thyroid response to iodized salt . DESIGN A st and ardized , commercially available , s and wich fluoroimmunometric serum thyroglobulin assay was adapted for use on blood spots and vali date d in Swiss children . In a 1-y prospect i ve study in 377 goitrous Moroccan children aged 6 - 15 y , the assay was used to measure thyroglobulin before and after the introduction of iodized salt .  Urinary iodine , thyroid volume , thyrotropin , and thyroxine were measured , and regression was done with thyroglobulin as the dependent variable . RESULTS Correlation between the blood spot and serum assays was excellent ( r = 0.98 ) . The SD of the difference between the blood spot and serum assays was 3.8 micro g/L ; the median CVs for the blood spot assay in controls and sample s were 6.3 % and 14.4 % , respectively . Median thyroglobulin was 24.5 ( range : 0 - 328.8 ) micro g/L at baseline and fell significantly after the introduction of iodized salt to 6.2 ( 0 - 83.1 ) and 4.4 ( 0 - 47.1 ) micro g/L at 5 and 12 mo , respectively ( P < 0.0001 ) . Regression of urinary iodine and thyroid volume on thyroglobulin was highly significant at baseline and at 5 mo ( P < 0.001 ) . CONCLUSION Thyroglobulin , measured in dried whole blood spots , may be a valuable indicator of improving thyroid function in children after supplementation with iodized salt Iodine deficiency control programs have greatly reduced iodine deficiency disorders worldwide . For monitoring changes in iodine status , different indicators may be used . The aim of this study was to evaluate the suitability of indicators of iodine status and thyroid function , thyroglobulin ( Tg ) , thyroid-stimulating hormone ( TSH ) and free thyroxine ( FT4 ) in serum , thyroid volume and urinary iodine concentration , in iodine-deficient schoolchildren under conditions of increasing iodine supply . The study was established as a double-blind , placebo-controlled oral administration of a single dose of iodized oil to schoolchildren ( 7 - 10 y old ) , living in an iodine-deficient area of Benin , with an observation period of 10 mo . However , 3 - 4 mo after supplementation , iodized salt became available in the area . The study population therefore comprised an iodized oil-supplemented group  and a nonsupplemented group  , both of which had variable , uncontrolled intakes of iodized salt during the last 6 mo of the study . Initial mean serum concentrations of TSH and FT4 were within the normal range , whereas serum Tg concentration , urinary iodine concentration and thyroid volume were indicative of moderate-to-severe iodine deficiency . At the end of the study , all indicators had improved significantly , except thyroid volume , which had decreased only in the supplemented group . The supplemented group also still had significantly lower serum Tg and higher urinary iodine concentrations than the nonsupplemented group . Serum Tg and urinary iodine concentrations are the indicators most influenced by a changing iodine supply . Current normal reference ranges of serum concentrations of TSH and FT4 are too wide for detecting iodine deficiency in this age group BACKGROUND Infants are highly vulnerable to iodine deficiency , and little data exist on the effect of multiple micronutrient supplementation on their iodine status . OBJECTIVE We aim ed to compare the efficacy of daily and weekly multiple micronutrient food-like tablets ( foodLETs ) on increasing iodine status among infants . DESIGN In a double-blind , placebo-controlled trial , 133 Indonesian males aged 6 - 12 mo were r and omly assigned to 1 of 4 groups : a daily multiple-micronutrient foodLET providing the Recommended Nutrient Intake (RNI)(DMM ) , a weekly multiple-micronutrient foodLET providing twice the RNI ( WMM ) , a daily 10-mg Fe foodLET ( DI ) , or placebo .  Urinary iodine ( UI ) concentrations were measured at baseline and at 23 wk . RESULTS At baseline , the average UI concentration ( 1.37 micromol/L ) was within the normal range , and 30.8 % of subjects had iodine deficiency ( UI < 0.79 micromol/L ) . At 23 wk , the DMM group had the highest increment in UI ; however , after adjustment for initial UI , the changes in UI were not significantly different between the 4 groups ( P = 0.39 ) . Initial UI correlated inversely with the changes in UI ( P < 0.001 ) . The DMM group had the greatest reduction and increment in the proportion of iodine-deficient infants and in infants with iodine excess , respectively ; however , no significant difference was found in these proportions ( P = 0.13 and P = 0.42 ) between the 4 groups . CONCLUSION Daily consumption of a multiple-micronutrient foodLET providing the RNI during infancy may be one strategy to improve iodine status Iodized salt and iodized oil are the main methods used to prevent iodine deficiency , but sometimes alternative approaches are needed . We tested the efficacy of various regimens for the intermittent administration of potassium iodide in Hwedza , Zimbabwe , an area of known severe iodine deficiency . We divided 304 schoolchildren aged 7 - 13 y into five equal groups that received iodine as a 10 % solution of potassium iodide as follows : 8.7 mg every 2 wk ( group A ) , 29.7 mg every month ( group B ) , 148.2 mg every 3 mo ( group C ) , 382 mg every 6 mo ( group D ) , or 993 mg once ( group E ) . The follow-up period was 13 mo . No adverse effects were encountered with any of these doses . After 6 mo , the median blood spot thyroglobulin concentration had decreased in all groups and had normalized in groups A and B to values found in iodine-sufficient population s. The number of children with elevated thyroid-stimulating hormone concentrations decreased in groups A-C , but the changes were not significant . Urine iodine concentration generally remained low in all groups but increased in group A. After 13 mo , mean thyroid volume measured by ultrasound had decreased in groups A and B to values comparable with those in iodine-sufficient areas , and was unchanged in the other groups . We conclude that oral potassium iodide is effective for the prophylaxis of iodine deficiency if given as a dose of 30 mg I monthly or 8 mg biweekly BACKGROUND In developing countries , many children are at high risk of goiter and iron deficiency anemia . Because iron deficiency can have adverse effects on thyroid metabolism , iron deficiency may influence the response to supplemental iodine in areas of endemic goiter . OBJECTIVE The aim of this study was to determine whether goitrous children with iron deficiency anemia would respond to oral iodine supplementation . DESIGN A trial of oral iodine supplementation was carried out in an area of endemic goiter in western Côte d'Ivoire in goitrous children ( n = 109 ) aged 6 - 12 y. Group 1 ( n = 53 ) consisted of goitrous children who were not anemic . Group 2 ( n = 56 ) consisted of goitrous children who had iron deficiency anemia . At baseline , thyroid gl and volume and urinary iodine , thyrotropin , and thyroxine were measured by using ultrasound . Each child received 200 mg I orally and was observed for 30 wk , during which urinary iodine , thyrotropin , thyroxine , hemoglobin , and thyroid gl and volume were measured . RESULTS The prevalence of goiter at 30 wk was 12 % in group 1 and 64 % in group 2 . The mean percentage change from baseline in thyroid volume 30 wk after administration of oral iodine was -45.1 % in group 1 and -21.8 % in group 2 ( P < 0.001 ) . Among the anemic children , there was a strong correlation between the percentage decrease in thyroid volume and hemoglobin concentration ( r(2 ) = 0.65 ) . CONCLUSION The therapeutic response to oral iodine was impaired in goitrous children with iron deficiency anemia , suggesting that the presence of iron deficiency anemia in children limits the effectiveness of iodine intervention programs Iodine supplementation before pregnancy in iodine-deficient women prevents cretinism and neuromotor deficits in their offspring . It is unclear whether iodine supplementation benefits cognitive function in iodine-deficient school-aged children . We therefore conducted a double-blind , r and omized , controlled trial of the effects of iodized poppy seed oil ( Lipiodol ) on cognitive and motor function and weight gain of iodine-deficient school children . The study was conducted with 305 children in grade s 1 and 2 from 10 primary schools in two iodine-deficient areas in Bangladesh . The children were stratified by school and grade and r and omly assigned to receive 400 mg of oral Lipiodol or a placebo . All children were given a battery of cognitive and motor function tests and had their weights , serum thyroxine ( T4 ) and thyroid-stimulating hormone ( TSH ) and urinary iodine levels measured before and 4 mo after the intervention . On enrollment , both groups were moderately iodine deficient ( median urinary iodine values : placebo group = 3.3 micromol/L , n = 148 ; iodine group = 3.1 micromol/L , n = 152 ; goiter prevalence in both groups > 95 % ) . However , their T4 and TSH levels were within the normal range . After 4 mo , there was a significant treatment effect on urinary iodine levels ( P < 0.0001 ) , but the levels of the treated group were still below normal ( median = 7.9 micromol/L ) . No significant differences were found in T4 and TSH levels , weight gain , cognitive or motor function . The findings suggest that Lipiodol supplementation in moderately iodine-deficient children with normal T4 levels is unlikely to benefit their cognitive function . However , it remains possible that other iodine preparations may have benefits BACKGROUND Iodine is required for the production of thyroid hormones , which are necessary for normal brain development and cognition . Although several r and omized trials examined the effect of iodine supplementation on cognitive performance in schoolchildren , the results were equivocal . OBJECTIVE We aim ed to ascertain whether providing iodized oil to iodine-deficient children would affect their cognitive and motor performance . DESIGN In a double-blind intervention trial , 10 - 12-y-old children ( n = 310 ) in primary schools in rural southeastern Albania were r and omly assigned to receive 400 mg I ( as oral iodized oil ) or placebo . We measured urinary iodine ( UI ) , thyroid-stimulating hormone ( TSH ) , and total thyroxine ( TT4 ) concentrations and thyroid gl and volume ( by ultrasound ) . The children were given a battery of 7 cognitive and motor tests , which included measures of information processing , working memory , visual problem solving , visual search , and fine motor skills .  Thyroid ultrasound and the biochemical and psychological tests were repeated after 24 wk . RESULTS At baseline , the children 's median UI concentration was 43 microg/L ; 87 % were goitrous , and nearly one-third had low concentrations of circulating TT4 . Treatment with iodine markedly improved iodine and thyroid status : at 24 wk , median UI in the treated group was 172 microg/L , mean TT4 was approximately 40 % higher , and the prevalence of hypothyroxinemia was < 1 % . In the placebo group after the intervention , these variables did not differ significantly from baseline . Compared with placebo , iodine treatment significantly improved performance on 4 of 7 tests : rapid target marking , symbol search , rapid object naming , and Raven 's Coloured Progressive Matrices ( P < 0.0001 ) . CONCLUSION Information processing , fine motor skills , and visual problem solving are improved by iodine repletion in moderately iodine-deficient schoolchildren BACKGROUND Iodine deficiency ( even moderate ) plays a major role in pregnancy associated goiter development , which is only party reversible after pregnancy . The prevalence of post partum thyroiditis is reported to be slightly lower in areas of iodine deficiency . Thus iodine supplementation may be effective in decreasing pregnancy associated increase in thyroid volume , but enhances the risk of increasing the prevalence of thyroid dysfunction in the post partum period . Therefore , we evaluated the effect of iodine supplementation ( with two different doses : 50 microg and 250 microg ) on the prevalence of post partum thyroiditis and the decrease in thyroid volume up to 8 months post partum in an area of mild iodine defic 
    Output:
    